Elavil (amitriptyline) Treatment Report
Generic Name: Amitriptyline
What is Elavil?
Elavil, a brand name for amitriptyline, is a tricyclic antidepressant approved for the treatment of depression. Off label amitripyline is used for certain chronic and neuropathic (nerve) pain and for prevention of migraine headaches.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Excess saliva | 11 |
|
2 | ||||
| Emotional lability | 5 | 0 | |||||
| Insomnia | 4 |
|
1 | ||||
| disease-related symptoms | 3 | 0 | |||||
| Pain | 1 | 0 | |||||
| Stiffness/Spasticity | 1 | 0 |
Mouse over the table for more information
Side Effects
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
2 | 50% |
|
|
Side effects too severe
|
2 | 50% |
|
|
Doctor's advice
|
1 | 25% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Patient Evaluations
See all 3 patient evaluations
-
- indyborn
- Sex: F
- Mouth/throat: moderate
- Arms: mild
- Chest: none
- Legs: none
- See profile
-
-
- indyborn
- 100 mg daily
- since May 23, 2009
-
Efficacy
Slight
for Excess saliva
-
Side Effects
None
- Advice/Tips this doesn't seem to be working for me, I will have to talk to my neuro about other alternatives See full evaluation
-
- Gabri
- Sex: F
- Mouth/throat: mild
- Arms: severe
- Chest: mild
- Legs: moderate
- See profile
-
-
- Gabri
- 25 mg daily
- since Apr 08, 2009
-
Efficacy
Major
for Insomnia
-
Side Effects
Mild
- Advice/Tips Lets me fall back asleep quicly when Iwake in the night See full evaluation
-
- alsking101
- Sex: M
- Mouth/throat: severe
- Arms: severe
- Chest: severe
- Legs: severe
- See profile
-
-
- alsking101
- 80 mg
- since Jan 01, 2006
-
Efficacy
Slight
for Excess saliva
-
Side Effects
Moderate
- See full evaluation
See all 3 patient evaluations
Report created on November 21, 2009.